Lifestyle & sleep: The Full Evidence

How does hayfever affect cognitive performance and productivity?

What the research says

Allergic rhinitis consistently impairs self-reported cognitive performance, work productivity, and quality of life, with studies showing significant presenteeism and absenteeism costs. However, objective cognitive testing reveals a more complex picture: while some controlled studies (e.g., Wilken et al. 2002) demonstrate measurable decrements in vigilance and cognitive functioning during allergen exposure, others (e.g., Kremer et al. 2002, Corpening et al. 2025) find no significant objective impairment, suggesting a disconnect between subjective complaints and measurable deficits. Real-world productivity data from multiple systematic reviews and large surveys nonetheless confirm substantial economic and occupational burden attributable to hayfever.

How it works

Proposed mechanisms include systemic and neuroinflammatory effects of allergic mediators (histamine, cytokines) disrupting attention and processing, compounded by sleep disruption from nasal congestion leading to fatigue and reduced cognitive reserve. Patients may compensate through increased effort, masking objective performance decrements during short-term testing while contributing to exhaustion and productivity loss over time.

---

Does hayfever increase anxiety or depression risk?

What the research says

Allergic rhinitis (hayfever) is consistently associated with significantly elevated risk of both depression and anxiety, with pooled odds ratios of approximately 1.4–1.9 across multiple meta-analyses encompassing tens of millions of individuals. A 2021 systematic review and a 2024 meta-analysis corroborate these findings, with severe AR associated with up to 2.7-fold greater depression risk compared to mild AR. The association holds across diverse study populations and designs, though effect sizes vary somewhat by adjustment for confounders.

How it works

Proposed mechanisms include cytokine-mediated neuroinflammation (driven by Th2-skewed immune responses), HPA axis dysregulation, and sleep disruption caused by nasal congestion and pruritus, all of which can impair mood regulation. Aeroallergen exposure has been temporally correlated with depressive episodes, suggesting a direct immunological trigger beyond the burden of chronic symptoms alone.

---

How does untreated hayfever affect sleep quality?

What the research says

Untreated allergic rhinitis (hayfever) is consistently associated with significant sleep impairment, including increased sleep disturbances, longer sleep onset latency, more frequent nocturnal awakenings, daytime somnolence, and fatigue compared to non-AR controls. A 2020 systematic review and meta-analysis confirmed these associations across observational studies, and a landmark 2006 cross-sectional study found that severity and duration of AR directly correlated with degree of sleep impairment as measured by validated tools. Sleep-disordered breathing, including snoring and apnea risk, is also elevated in untreated AR patients.

How it works

Nasal congestion from IgE-mediated inflammation obstructs airflow, worsening in the supine position and promoting mouth breathing, snoring, and sleep-disordered breathing. Concurrently, histamine released during allergic reactions directly promotes wakefulness and arousal via hypothalamic pathways, while pro-inflammatory cytokines further dysregulate sleep-wake control.

---

Do sedating antihistamines impair driving and work performance?

What the research says

Sedating (first-generation) antihistamines such as diphenhydramine, clemastine, and triprolidine produce significant, objectively measurable impairment of driving performance and work-related psychomotor skills, with deficits comparable to or exceeding those caused by moderate alcohol intoxication (BAC ~0.1%). A critical and clinically important finding is that subjective drowsiness does not reliably predict actual performance impairment, meaning users cannot self-assess their fitness to drive. Second-generation antihistamines (e.g., fexofenadine, loratadine) generally show minimal driving impairment comparable to placebo, though inter-drug variability exists and some agents like cetirizine may impair a subset of individuals.

How it works

First-generation antihistamines readily cross the blood-brain barrier due to their lipophilicity and lack of P-glycoprotein efflux, allowing central H1 receptor antagonism that produces sedation, slowed reaction time, and impaired psychomotor coordination. Second-generation agents are engineered to have lower CNS penetrance through greater polarity or active efflux mechanisms, substantially reducing but not entirely eliminating central sedative effects.